Bio Green Med Solution (BGMS) vs Enlivex (ENLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Enlivex is the larger company by market cap ($5.5 million vs $5.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGMS | ENLV |
|---|---|---|
| Share price | $0.821 | $0.277 |
| Market cap | $5.44M | $5.51M |
| 1-day change | -3.41% | -10.85% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-5.02 | $494.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.70 | $27.15 |
| 52-week low | $0.57 | $0.255 |
| Distance from 52-week high | -87.75% | -98.98% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +28780.87% |
| Average volume | 74.12K | 945.30K |
| Shares outstanding | 6.62M | 19.91M |
| Employees | — | 34 |
| Sector | Industrials | Healthcare |
| Industry | Building Products & Equipment | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Bio Green Med Solution in Industrials and Enlivex in Healthcare.
About Bio Green Med Solution
BGMS stock →Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.
Industrials · Building Products & Equipment
About Enlivex
ENLV stock →Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2.
Healthcare · Biotechnology · 34 employees
BGMS vs ENLV FAQ
Which is bigger, Bio Green Med Solution or Enlivex?
Enlivex (ENLV) is larger, with a market capitalization of $5.51M compared with $5.44M for Bio Green Med Solution (BGMS).
Are Bio Green Med Solution and Enlivex in the same industry?
No. Bio Green Med Solution is in the Industrials sector, while Enlivex is in Healthcare.